Rainmed Medical Limited (2297) Stock Statistics & Valuation Metrics

Rainmed Medical Limited has a market cap or net worth of HK$462.45M. The enterprise value is HK$99.33M.

Rainmed Medical Limited has 1,401,358,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Rainmed Medical Limited’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -27.21%.

The current PE Ratio of Rainmed Medical Limited is ―. Rainmed Medical Limited’s PEG ratio is ―.

In the last 12 months, Rainmed Medical Limited had revenue of 39.82M and earned -113.50M in profits. Earnings per share was -0.10.

In the last 12 months, operating cash flow was -41.19M and capital expenditures -6.71M, giving a free cash flow of -47.90M billion.

Rainmed Medical Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Rainmed Medical Limited upcoming earnings date is Mar 26, 2026, TBA (Confirmed).

Rainmed Medical Limited as a current ratio of 4.92, with Debt / Equity ratio of 6.28%

In the past 12 months, Rainmed Medical Limited has paid 242.00K in taxes.

Rainmed Medical Limited EV to EBITDA ratio is -1.85, with an EV/FCF ratio of 0.00.

Rainmed Medical Limited has HK$205.55M in cash and marketable securities with HK$25.58M in debt, giving a net cash position of HK$179.97M billion.

Gross margin is 59.93%, with operating margin of -297.04%, and net profit margin of -284.99%.

The average price target for Rainmed Medical Limited is HK$0.50, which is 11.43% higher than the current price. The consensus rating is Hold